MACHATHA STEPHEN (Chief Development Officer) sold 6.3% of their position (16.04K shares) of ALDEYRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $76.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/14/2024ACC: 0000950170-24-097071
Officer· Chief Development Officer
Since Dec 2020
-16.04K
Net shares
Net seller
$76.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.04K
Price / share
$4.74
Trade value
$75.97K
% of position
6.3%
8/12/2024
252.81K→236.77K
Total
Net shares
−16.04K
Net value
-$75.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2024 | S · Sale | −16.04K | $4.74 | $75.97K | 6.3% | 252.81K | 236.77K |
| Total | −16.04K | -$75.97K | ||||||
Derivative Transactions0
No derivative transactions reported